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The authors regret to inform that incorrect concentrations of the
individual components of the inflammatory stimulus were reported in
the original article's Supplementary Table 1.
The corrected Supplementary Table 1 reads as follows:
Component Species Company Solvent Concentration
LPS Escherichia coli
O111:B4
Sigma
Aldrich
PBS (Biochrome),
DMEM
10 μg/ml
TNF-α Human Peprotech Ampuwa®
(Fresenius Kabi)
5 μg/ml
IL-1β Human Peprotech PBS + 0,1% BSA 1 μg/ml
IFN-γ Human Peprotech PBS + 0,1% BSA 1 μg/ml
IL-6 Human Peprotech PBS + 0,1% BSA 1 μg/ml
Accordingly, the first sentence in the Material and methods section
2.2 needs to read “Inflammatory conditions were simulated using an
inflammatory stimulus (LPS + Cyt) containing the endotoxin lipopo-
lysaccharide (LPS, 10 μg/ml, see Suppl. Table 1) and the pro-in-
flammatory cytokines TNF-α (5 μg/ml), IL-1β (1 μg/ml), IFN-γ (1 μg/
ml) and IL–6 (1 μg/ml).”
It can be genuinely assured that this mistake does not affect the
scientific conclusions drawn in the original article.
The authors would like to apologise for any inconvenience caused.
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